Edition:
India

People: Zogenix Inc (ZGNX.OQ)

ZGNX.OQ on NASDAQ Stock Exchange Global Market

50.01USD
23 Aug 2019
Change (% chg)

$-0.00 (-0.00%)
Prev Close
$50.01
Open
$51.30
Day's High
$52.13
Day's Low
$49.59
Volume
170,380
Avg. Vol
170,871
52-wk High
$56.48
52-wk Low
$33.56

Smith, Michael 

Mr. Michael P. Smith is the Chief Financial Officer, Executive Vice President, Treasurer, Secretary of Zogenix Inc, since January 16, 2017. Mr. Smith has served as our Executive Vice President, Chief Financial Officer, Treasurer and Secretary since January 2017. From January 2015 through December 2016, Mr. Smith served as Chief Financial Officer of Raptor Pharmaceutical Corp., a global biopharmaceutical company focused on the development and commercialization of transformative therapeutics for rare diseases that was acquired by Horizon Pharma plc. in October 2016. In this role, he was responsible for the finance, accounting, corporate development, corporate strategy, intellectual property, and information management business functions. From May 2012 to January 2015, Mr. Smith served as Chief Financial and Business Advisor at Catalyst Biosciences. Prior to that role, from September 2010 to April 2011, he was Vice President of Business Development at iPierian, Inc., and from June 2006 to July 2009, he served as Head of Business Development and Chief Financial Officer of Memory Pharmaceuticals Corporation. Mr. Smith received his B.S. in Commerce from the University of Virginia and his M.B.A. from the Haas School of Business at the University of California, Berkeley.

Basic Compensation

Total Annual Compensation, USD 567,250
Restricted Stock Award, USD 266,563
Long-Term Incentive Plans, USD --
All Other, USD 1,159,980
Fiscal Year Total, USD 1,993,790

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Cam Garner

517,899

Stephen Farr

6,650,250

Michael Smith

1,993,790

Gail Farfel

2,355,940

Bradley Galer

2,554,870

Ashish Sagrolikar

4,156,790
As Of  31 Dec 2018